US Patent 8846386 sVEGFR-2 and its role in lymphangiogenesis modulation
Patent 8846386 was granted and assigned to University of Kentucky on September, 2014 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 8846386 sVEGFR-2 and its role in lymphangiogenesis modulation
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.